Skip to main content
PAINWeek 2024 Main banner
Icon Legend
This session is not in your agenda.
This session is in your agenda. Click to remove it

Full Schedule

  1. Home
  2. Full Schedule
Sort by Full Schedule      Sort by Title      Sort by Track      Sort by Faculty  

Full Schedule

  • Cancelled
  • A Case Report of an 80-year-old Patient Given Once Daily Diclofenac Epolamine Topical System 1.3% as a Nonsteroidal Anti-Inflammatory Drug Therapy While on an Anticoagulant
  • A Preliminary Examination of the Feasibility, Appropriateness, and Effectiveness of Virtual Group-Based Acceptance and Commitment Therapy for Chronic Pain (ACT-CP) in Veterans
  • A Qualitative Assessment of Surgeon Perceptions and Experiences with Acute Pain Management
  • A retrospective analysis on the benefits of an over-the-counter combination of aspirin, acetaminophen, and caffeine (AAC) in menstrual migraine.
  • A Retrospective Case Series Demonstrating the Effectiveness of Regenerative Injection Therapies in Chronic Pain Conditions
  • A retrospective cohort study comparing persistence between rimegepant and oral triptans for the acute treatment of migraine in the United States.
  • A Review of the Primary and Secondary Outcomes From a Phase I Study Comparing the Respiratory Effects of Buprenorphine Buccal Film and Oral Oxycodone Hydrochloride Administration
  • A Survey of Pharmacists on Naloxone Prescribing: Where to Next?
  • A Systematic Review of the Effectiveness of Turmeric in Post-Procedural Pain Reduction
  • AI-powered Personalized Pain Management: Evaluating the Clinical Efficacy of Paindrainer® in Enhancing Daily Function and Reducing Pain Interference
  • An evaluation of effectiveness of high concentration capsaicin topical system in post herpetic neuralgia
  • An evaluation of effectiveness with HCCTS across RCT vs RWE data for one year treating painful diabetic peripheral neuropathy
  • An Evaluation of the Incidence of Opioid Use Disorder Among People with Acute and Chronic Pain Managed with Prescription Opioids and the Associated Economic and Societal Burden in the United States
  • An Integrated Approach to Pain Management in Chronic Prostatitis: A Case Study
  • Are patients’ perceived preoperative pain tolerance and concern predictive of postoperative outcomes?
  • Ascending and Descending Pain Pathways as a Coupled Control & Feedback Loop: System-theoretical Modeling
  • Assessing Opioid Prescribing Practices for Opioid-Naïve Surgical Patients
  • Assessing the Gaps in Healthcare Professionals’ Understanding and Credibility of Self-Healing for Musculoskeletal Pain: A Global Survey Study
  • Assessing the Market Need for Advanced Postoperative Respiratory Depression Treatment
  • Auricular Therapy: An Adjunctive Treatment for Pain Management
  • Avascular Necrosis of Hip confounding the clinical picture and treatment response of Lumbar Radiculopathy
  • Behavioral and neural mechanisms supporting psilocybin assisted therapy for chronic phantom limb pain
  • Characterization of Pain Management Regimens For Inpatients Receiving Bolus Ketorolac For Post-Surgical Pain Management – Results of a Retrospective Chart Audit of 597 Patient Records in 101 Hospitals Across the United States
  • ChatGPT for Migraine Patient Education: Ready for Prime Time?
  • Chronic Axial Low Back Pain and Bertolotti's Syndrome in an Older Patient: A Case Report
  • Comparative Sensory Analysis of Novel Topical Diclofenac Hydrogel with Conventional Diclofenac Gel
  • Comparison of Nonmedical Use of Buprenorphine Products for Analgesia Compared to Other Opioid Medications in Adults Evaluated for Substance Use with the Addiction Severity Index-Multimedia Version (ASI-MV®)
  • Considering the role of hip dysfunction in pelvic pain
  • Curbing Opioid Abuse: Real-World Evidence of Abuse-Deterrent Formulations
  • Decreased Cost Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis.
  • Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis
  • Development of a Simulation-Based Intrathecal Drug Delivery Course in a Fellowship/Residency Setting
  • Dextrose Prolotherapy as a Treatment for Thumb Pain: A Case of a Hobby Video Gamer
  • Does a Migraine AI Assistant (Maia) Improve Patient Knowledge and Confidence? A Pilot Evaluation
  • Educating APRNs and PAs in Pain Management - A Needs Assessment
  • Effectiveness of a systematic Iterative Imperative Prayer on pain intensity.
  • Effects of morphine to fentanyl interchange in post-anesthesia care unit order sets
  • Efficacy and Safety of Meloxicam Co-Crystal and a Rapid-Absorption Formulation of Meloxicam in The Treatment of Post-Surgical Dental Pain.
  • Efficacy of a Novel Audio-Visual Neuromodulation device for Neuropathic Pain: A Randomized Controlled Trial
  • Efficacy of celecoxib oral solution in participants with insufficient response to triptans for the acute treatment of migraine: pooled results from a post-hoc analysis of 2 phase 3 randomized clinical trials
  • Empowering orthopaedic patients: a patient-centred approach to optimising postoperative analgesic education.
  • Enabling Patient Initiated Opioid Tapering Using Telemedicine Opioid Education Shared Medical Appointments
  • Enhancing Buprenorphine Access in Primary Care at Veteran Affairs Facilities: The Role of In-Person Pharmacist-led Workshops
  • Evaluating Carpal Tunnel Syndrome Severity Using Handheld Point-of-Care Ultrasound (POCUS): A Case Study
  • Evaluating Insurance Reimbursement for Kyphoplasty in an Outpatient Setting: A Comparative Analysis
  • Evaluating Patients' Perceptions of Integrative Therapies and Self-Healing for Musculoskeletal Pain: A Worldwide Survey
  • Evaluating the Efficacy of Prophylactic NSAIDs in Reducing Pain During Intrauterine Device Placement: A Systematic Review
  • Evaluation of Opiate Usage for Acute Non-surgical Pain
  • Evaluation of the Safety and Efficacy of Cryopreserved Human Umbilical Cord Tissue Allograft for the Supplementation of Cartilage Defects Associated with Hip Osteoarthritis: An Observational Retrospective Study
  • Exploring Historical and Novel Respiratory Stimulants for Postoperative Respiratory Depression Treatment
  • Exposures Reported to US Poison Centers Involving Buprenorphine Products for Analgesia Compared to Other Opioid Medications
  • Female Sexual Function in Small Fiber Neuropathy
  • Fentanyl’s Physiochemistry Influences its Unique Pharmacology and Abuse
  • First-in-Human Study of the TRPV1 Agonist RTX-GRT7039 for Knee Osteoarthritis Pain
  • Genicular Nerve Radiofrequency Ablation use in varied knee pathologies; A case series
  • Global Survey: Perceptions of Healthcare Providers and Patients on Self-Healing for Musculoskeletal Pain
  • Healthcare Costs and Resource Use among Chronic Low Back Pain Patients Treated with Belbuca or Buprenorphine Transdermal Patches: A Retrospective US Medicare Claims Analysis
  • Implementing routine substance use disorder screening in a rural family practice
  • Investigating the Mechanism of Dextrose Prolotherapy on Fibroblast and Chondrocyte Cell Viability
  • Investigating Thermal Skin Response to Menthol Containing Topical Products
  • Is There Value in Using an Adductor Canal Catheter in Knee Arthroplasty? A Randomized Clinical Trial
  • MEDICAID POLICY OVERVIEW OF OPIOID MANAGEMENT FOR SICKLE CELL DISEASE ACROSS STATES
  • MEDICATION USE EVALUATION OF ERENUMAB (AIMOVIG) A CGRP MONOCLONAL ANTIBODY FOR MIGRAINE PROPHYLAXIS
  • Multimodal Analgesia Following Major Spinal Reconstructive Surgery Improves Postoperative Pain and Function
  • Multimodal and Interdisciplinary Interventions for the Treatment of Localized Provoked Vulvodynia: A Scoping Review of the Literature from 2010 to 2023.
  • Nonmedical Use and Route of Administration of XTAMPZA® ER versus Other Oxycodone Medications (Extended- and Immediate-Release) in Adults Evaluated for Substance Use with the Addiction Severity Index-Multimedia Version (ASI-MV®)
  • NTM-001 (Ketorolac Tromethamine 24 Hour Continuous Infusion): A 48-Hour Toxicity and Toxicokinetic Study in Minipigs, with a 14-Day Recovery Period
  • Ongoing Treatments with High Concentration Capsaicin Topical System Results in Progressive Pain Reduction for Painful Diabetic Neuropathy: A Retrospective Real-World Analysis
  • Opioid Consumption Patterns Before and After Elective Joint Replacement Surgery
  • Pain and Substance Abuse Integration into Medical School Education: A Case Report
  • PainScript’s Mobile Health Engagement in Managing Chronic Pain: A Retrospective Analysis of Patient Adoption and Sustained Use
  • Patient Reported Burden of Disease in Postherpetic Neuralgia Pain: Learnings from In-depth Patient Interviews, Sub-study of RELIEF-PHN-1
  • Personalized Chronic Pain Management: Assessing the Societal Impact and Cost-Effectiveness of PainDrainer®
  • Pharmaceutical Automated Reporting: An Opioid Stewardship Tool
  • Physical Modalities for the Treatment of Localized Provoked Vulvodynia: A Scoping Review of the Literature from 2010 to 2023.
  • Post-hoc Analysis of Individual Questions from the Australian/Canadian Osteoarthritis Hand Index from a Randomized, Double-Blind, Placebo-Controlled Trial of Patients with Hand OA
  • Post-Spaceflight Evaluation of Neck Force Control and Neck Muscle Activation in Astronauts
  • Preferences and Experiences of Over-the-Counter Analgesics for Osteoarthritis Signs and Symptoms
  • Prevalence of Multidisciplinary Pelvic Symptoms at Intake of Patients with Chronic Pelvic Pain to a Single Academic Institution.
  • Psychological Modalities for the Management of Localized Provoked Vulvodynia: A Scoping Review of the Literature from 2010 to 2023.
  • Psycho-Social Predictors of Treatment Effectiveness From Skills-Based VR-Delivered Therapy? Secondary Analysis of a Randomized Controlled Trial in Chronic Low Back Pain
  • Real-world treatment outcomes and patterns of rimegepant for the treatment of migraine in the Guangdong-Hong Kong-Macao Greater Bay Area of China: interim results.
  • Retrospective analysis of Dorsal Column Stimulation and its effect on controlling chronic pain
  • Retrospective Claims Analysis of Decreased Healthcare Visits and Costs with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch
  • Review of OTC Topical Analgesics for the Treatment of Minor Acute Pain Conditions
  • RFUS-301: Superior Safety and Extended Local Anesthetic Efficacy in Animal Studies
  • Safety and Analgesic Effect of the TRPV1 Agonist RTX-GRT7039 in Osteoarthritis Knee Pain
  • Safety and Efficacy of Wharton’s Jelly Connective Tissue Allograft for Rotator Cuff Tears: Findings from a Retrospective Observational Study
  • Safety and Tolerability of Schedule III Buprenorphine and Oral Schedule II Opioid Treatment in Chronic Low Back Pain Patients: A Retrospective US Medicare Claims Analysis
  • Satisfaction with treatment outcomes in people with migraine receiving rimegepant or triptans: a descriptive analysis from a real-world migraine tracking app
  • Severity risk assessment of opioid-induced respiratory depression or overdose in patients with cancer
  • Shoulder Pain Management for Patients: A Mobile Application for Interventional Pain Options
  • Significance of Morphine Milligram Equivalents in the 5 Days Prior to Acute Inpatient Rehabilitation Stay
  • Single center, retrospective analysis to predict opioid-induced oversedation and respiratory depression utilizing a modified Oversedation Risk Criteria score in patients with cancer
  • Single-Center Retrospective Study of Flowable Umbilical Cord Tissue Allograft Application in Temporomandibular Joint Defects: An Investigative Case Series
  • SMART™ Opioids with Unprecedented Protection Against Abuse and Oral Overdose – Human Proof-of-Concept
  • Study design for testing safety, tolerability, and efficacy of NTM-006 against pain symptoms associated with Fragile X Tremor/Ataxia Syndrome (FXTAS)
  • Subcutaneous Opioids: Under the Skin Irritation or New Standard of Care?
  • The Effect of a Brief Action Planning Telephone Intervention in Patients with Chronic Pain
  • The Effects of Cebranopadol on Ventilatory Drive, Central Nervous System, and Pain
  • The Impact of an Interprofessional Educational Summit on Healthcare and Law Enforcement Professionals’ Perceptions and Readiness Regarding Collaborative Substance Misuse Prevention and Treatment
  • The importance of gait preservation in the elderly with diabetes
  • The Promise of In-Home VR-Delivered Skills-Based Therapy for Chronic Low Back Pain: Results from Two Randomized Sham-Controlled Trials
  • The role of the carotid body for reversal of opioid-induced respiratory depression
  • Tramadol for Pain Management Associated with Serotonin Syndrome
  • Treating Osteoarthritis Pain: How Effective Are Immediate- and Extended-Release Acetaminophen Products?
  • Treatment Characteristics and Dosing Patterns in Chronic Low Back Pain Patients Treated with Belbuca® and Buprenorphine Transdermal Patches: A Retrospective US Medicare Claims Analysis
  • Umbilical Cord Connective Tissue Allograft Applications with EPAT and Class IV Lasers for Defects of the Plantar Fascia: A Retrospective Case Series
  • Umbilical Cord Tissue Allograft Defects for Ligamentous Injuries in Patients with Sinus Tarsitis: A Case Series
  • Undiagnosed Neurological Conditions in Chronic Pelvic Pain: More Common Than We Think
  • Unexpected Stripes in the Herd: A Rare Case of Neuropathy and Weakness.
  • Unintentional Extradural Pneumocephalus: A Unique Case Report of Post-Procedural Headache After Lumbar Epidural Steroid Injection
  • Unlocking the Brain's Pain Relief Potential: Exploring Psychedelic-Assisted Therapy for Chronic Pain
  • Urine Drug Screens: Assessing Prescriber Interpretation and Outcomes in Chronic Opioid Therapy
  • Video Screening Exam to Determine Hip Etiologies of Chronic Pelvic Pain
  • Virtual Comprehensive Pain Care: Outcomes from an Interdisciplinary Approach in 71 Patients
  • Weekly Opioid Shared Medical Medication Monitoring Appointments To Remediate Issues Of Chronic Pain Patient Adherence, Aberrance And Noncompliance.
  • Tuesday, September 3, 2024
  • 6:30 AM – 7:20 AM PST
    Registration/Morning Coffee
  • 6:45 AM – 7:15 AM PST
    PAINWeek 101
  • 7:30 AM – 8:20 AM PST
    Breaking the Cycle: Ultra Brief Psychological Interventions to Prevent Opioid Abuse
  • 7:30 AM – 8:20 AM PST
    Missed Cause of Misery: Nerve Sensitization (Nociplastic Pain)
  • 7:30 AM – 8:20 AM PST
    Potent Poisoning: When Sleeping Beauty Gets a Bad Apple
  • 7:30 AM – 8:20 AM PST
    Women and Migraine: Throughout the Lifespan
  • 8:30 AM – 9:30 AM PST
    From Evidence to Practice: New Results from a 1-Year Real-World Study Supporting Use of Topical Capsaicin for Painful Diabetic Peripheral Neuropathy of the Feet
  • 9:40 AM – 10:30 AM PST
    House of Pain: Get Out Your Seat and...Manage Sickle Cell Pain!
  • 9:40 AM – 10:30 AM PST
    Jack-of-All-Trades: Pharmacology Review of Buprenorphine and Methadone in the Palliative Care Setting
  • 9:40 AM – 10:30 AM PST
    Mobile Health: Compliance, Value Add, Revenue & Real-World Evidence of Clinical Outcomes
  • 9:40 AM – 10:30 AM PST
    Stress, Anxiety, and Insomnia, Oh My! Integrative Medical Approaches for These Co-Morbid Pain Drivers
  • 10:30 AM – 11:00 AM PST
    Break
  • 11:00 AM – 11:50 AM PST
    Complexities and Dimensions of Migraine Care: The Burden of Migraine in the Older Adult Population and How to Optimize Treatment Selection
  • 11:00 AM – 11:50 AM PST
    Initiation Without Precipitation: The Nitty-Gritty of Starting Buprenorphine
  • 11:00 AM – 11:50 AM PST
    Neuromodulation for the Front Line Providers
  • 11:00 AM – 11:50 AM PST
    Poking Around: An Introduction and Integration of Acupuncture Into Your Practice
  • 12:00 PM – 1:00 PM PST
    NAVIGATING MIGRAINE TREATMENT: Patient-Focused Strategies for Primary Care
  • 1:10 PM – 2:00 PM PST
    Creating a Specialty Pain Education Curriculum for Advanced Practice Providers
  • 1:10 PM – 2:00 PM PST
    Opioid Odyssey: Navigating the Stewardship Seas
  • 1:10 PM – 2:00 PM PST
    Sink or Swim: Pain Management Approaches for the Clinical Conundrums
  • 1:10 PM – 2:00 PM PST
    Working With Culturally Diverse Patients: A Pain Management Psychologist Perspective
  • 2:10 PM – 3:00 PM PST
    A Classic With a New Twist: The Utilization of Buprenorphine in the Chronic Pain Patient
  • 2:10 PM – 3:00 PM PST
    Red Alert: When Period Pain Becomes a Problem
  • 2:10 PM – 3:00 PM PST
    The “Other” Back Pain: Sacroiliac Joint Pain
  • 2:10 PM – 3:00 PM PST
    Three Patients, Three Stories, One Challenging Disease: Examining Complex Regional Pain Syndrome Through the Patient’s Perspective
  • 3:00 PM – 3:30 PM PST
    Break
  • 3:00 PM – 4:20 PM PST
    VA/Government Services Reception
  • 4:30 PM – 5:20 PM PST
    Keep the Fire Going: Chronic Stress and "Burn Out" – Helping Us to be Better for Our Patients
  • 4:30 PM – 5:20 PM PST
    Optimizing Quality of Life for Cancer Patients through Pain Management
  • 4:30 PM – 5:20 PM PST
    Partnering in Pain: Navigating Shared Experiences in Endometriosis Pain Management
  • 4:30 PM – 5:20 PM PST
    Riddle Me This? Unraveling Unexpected Urine Drug Tests and Strategies to Interpreting Perplexing Puzzling Results
  • 5:30 PM – 8:30 PM PST
    Applying Best Practices in Pain Management: Delivering Holistic Patient-Centered Care to Minimize Health Disparities and Adverse Opioid Outcomes
  • Wednesday, September 4, 2024
  • 6:30 AM – 7:20 AM PST
    Registration/Morning Coffee
  • 7:30 AM – 8:20 AM PST
    Appropriate Patient Selection for Neuromodulation: Identification and Management of Post-Op Complications
  • 7:30 AM – 8:20 AM PST
    Communication Matters! How Improving Communication Skills Can Augment Pain Management in Patients with Chronic Pelvic Pain
  • 7:30 AM – 8:20 AM PST
    Foundations of Psychedelic Medicine: A Clinical Perspective
  • 7:30 AM – 8:20 AM PST
    The Role of a Pain Management Psychologist in a Multidisciplinary Team
  • 8:30 AM – 9:30 AM PST
    Responsible Pain Management With Opioid Therapy for Patients With Severe and Persistent Pain
  • 9:40 AM – 10:30 AM PST
    A DO, A PA, and A Clinical Pharmacist Walk Into a Room...An Interprofessional Collaboration
  • 9:40 AM – 10:30 AM PST
    Mitigating Opioid Misuse Through Tamper-Resistant Formulations: What's the Evidence?
  • 9:40 AM – 10:30 AM PST
    Real World Evidence on Psychedelics for Pain - Patient Perspectives
  • 9:40 AM – 10:30 AM PST
    The Devil is in the Details: Post-Covid Pain Syndromes
  • 10:30 AM – 11:00 AM PST
    Exhibit Hall Break
  • 11:00 AM – 11:50 AM PST
    A Novel Approach: Preventing & Treating Chronic Pain Due to Obesity in the Healthcare Setting
  • 11:00 AM – 11:50 AM PST
    A Show of Hands: The Art and Science of Physical Examination Part I: Headaches, Neck and Upper Extremity Pain
  • 11:00 AM – 11:50 AM PST
    Injections, Nerve Blocks, Pumps, and Neuromodulation
  • 11:00 AM – 11:50 AM PST
    Substance Struggles: Confronting Controlled Substance Mishandling and Addiction in Healthcare
  • 12:00 PM – 1:00 PM PST
    Anatomy of Pain: A Guide to Pain Signaling Pathways
  • 12:00 PM – 1:00 PM PST
    What to Do When Pain Relief With Gabapentinoids Isn’t Enough?
  • 1:10 PM – 2:00 PM PST
    (Unmasking Subjectivity: The Complex World of AI in Pain Assessment) Round I: The Good, How AI Will Make Pain Care Equitable
  • 1:10 PM – 2:00 PM PST
    Analgesics of the Future
  • 1:10 PM – 2:00 PM PST
    Beyond the Bedside: From Clinical Expert to Influential Leader
  • 1:10 PM – 2:00 PM PST
    FIRE AND ICE: Acupuncture For the Treatment of Women Veterans With Co-Morbid Pain and Menopause
  • 2:10 PM – 3:00 PM PST
    AI in Pain Management: Promising or Problematic?
  • 2:10 PM – 3:00 PM PST
    Malevolent MEDDs: The Lost Art of Morphine Equivalency Utilization
  • 2:10 PM – 3:00 PM PST
    Micro Induction of Buprenorphine in Sickle Cell Pain
  • 2:10 PM – 3:00 PM PST
    The Underutilized Role of Diagnostic Blocks in Interventional Pain
  • 3:10 PM – 4:10 PM PST
    Keynote - Through The Eyes of a Patient: Transforming Pain Into A Thriving Life
  • 4:15 PM – 6:15 PM PST
    Welcome Reception
  • 5:00 PM – 5:30 PM PST
    Expert Opinion Live - Revisiting Individualized Assessment and Management of OA in the Post COVID-19 Era
  • Thursday, September 5, 2024
  • 6:30 AM – 7:20 AM PST
    Registration/Morning Coffee
  • 7:30 AM – 8:20 AM PST
    Awkward Conversations: Managing Patients with Chronic Pain
  • 7:30 AM – 8:20 AM PST
    Have No Fear if OUD is Here! Simplifying Pain Management and Concomitant Opioid Use Disorder
  • 7:30 AM – 8:20 AM PST
    I’ll Have My Pain Medication Shaken, Not Stirred: Drug Interactions to Consider in Pain Management
  • 7:30 AM – 8:20 AM PST
    Painful Puzzles: Decoding Pain Needs in Patients with Dementia
  • 8:30 AM – 9:30 AM PST
    Frontline Opioid Prescribing: Rebalancing Benefit-Risk to Improve Outcomes
  • 8:30 AM – 9:30 AM PST
    Maximizing Time With Patients: An Interactive Discussion Between Patient and Provider About Opioid-Induced Constipation (OIC)
  • 9:40 AM – 10:30 AM PST
    Chronic Headache: Non-Invasive Vagal Nerve Stimulation
  • 9:40 AM – 10:30 AM PST
    Combat at the Front Line: Incorporating Drug Monitoring Programs Into Practice
  • 9:40 AM – 10:30 AM PST
    Implicit Biases in Opioid Prescribing Decisions
  • 9:40 AM – 10:30 AM PST
    Navigating the Legal Landscape: Psychedelic Therapy Integration
  • 10:30 AM – 11:00 AM PST
    Exhibit Hall Break
  • 11:00 AM – 11:50 AM PST
    (Unmasking Subjectivity: The Complex World of AI in Pain Assessments) Round II: The Ugly, Maybe Even COMPUTERS Have Race, Gender, and Class Bias
  • 11:00 AM – 11:50 AM PST
    A Show of Hands: The Art and Science of Physical Examination Part II: Back and Lower Extremity Pain
  • 11:00 AM – 11:50 AM PST
    Customized is Always Better: Individualized Diets and Supplementation in Migraine
  • 11:00 AM – 11:50 AM PST
    Never Again! Nephrolithiasis (Kidney Stone Pain Management)
  • 12:00 PM – 1:00 PM PST
    Break the Mold in Pain Biology: The Promise of a New Mechanism That May Overcome the Shortfalls of Current Moderate to Severe Pain Medications
  • 1:10 PM – 2:00 PM PST
    Case Based Pearls in Pelvic Pain: A Tutorial Anchored in Clinical Scenarios to Bring to Your Practice
  • 1:10 PM – 2:00 PM PST
    Evidenced-Based Care of Back Pain
  • 1:10 PM – 2:00 PM PST
    Implementation of Psychedelic Care Models: Risk Assessments & Addressing Adverse Outcomes
  • 1:10 PM – 3:00 PM PST
    (2 hour course) Going Down to the River to Pray: What APPs Need to Know About the Legal Side of Pain Management - Panel and Q&A
  • 2:10 PM – 3:00 PM PST
    Debate: The High and Lows of Medical Cannabis for Chronic Pain
  • 2:10 PM – 3:00 PM PST
    Kratom: What Pain Healthcare Providers Should Know
  • 2:10 PM – 3:00 PM PST
    Nourishing Nerves: Navigating Nutrition-Driven Pain Management
  • 3:00 PM – 3:30 PM PST
    Exhibit Hall Break
  • 3:00 PM – 3:30 PM PST
    Expert Opinion Live - Say No To Drugs: Neuromodulation Modalities for Migraine and Pain Management
  • 3:30 PM – 4:20 PM PST
    Identifying and Treating Patients With Unresolved Painful Diabetic Peripheral Neuropathy
  • 4:30 PM – 5:20 PM PST
    Can Artificial Intelligence Personalize Pain Treatments?
  • 4:30 PM – 5:20 PM PST
    Lend an Ear: Auricular Therapy Protocols for Pain Management
  • 4:30 PM – 5:20 PM PST
    What's the Deal? The WHO LBP Guidelines Meet the Ones From the VA/DoD
  • 4:30 PM – 5:20 PM PST
    When is Surgery a Good Option for Managing Chronic Pelvic Pain?
  • 5:30 PM – 6:45 PM PST
    Scientific Poster/Networking Reception
  • 5:35 PM – 5:45 PM PST
    (Scientific Abstract Poster Live Presentation) Real-world Treatment Outcomes and Patterns of Rimegepant for the Treatment of Migraine in the Guangdong-Hong Kong-Macao Greater Bay Area of China: Interim Results
  • 5:50 PM – 6:00 PM PST
    (Scientific Abstract Poster Live Presentation) Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis
  • 6:05 PM – 6:15 PM PST
    (Scientific Abstract Poster Live Presentation) Decreased Cost Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis
  • 6:20 PM – 6:30 PM PST
    (Scientific Abstract Poster Live Presentation) Investigating Thermal Skin Response to Menthol Containing Topical Products
  • 6:35 PM – 6:45 PM PST
    (Scientific Abstract Poster Live Presentation) Efficacy and Safety of Meloxicam Co-Crystal and a Rapid-Absorption Formulation of Meloxicam in The Treatment of Post-Surgical Dental Pain
  • Friday, September 6, 2024
  • 7:30 AM – 11:50 AM PST
    Auricular Therapy Workshop
  • 7:45 AM – 8:30 AM PST
    Registration/Morning Coffee
  • 8:40 AM – 9:30 AM PST
    Are the Psychosocial Components of the Biopsychosocial Approach Really Important? The Risks of Not Integrating Behavioral Health
  • 8:40 AM – 9:30 AM PST
    Geriatric Pain Management: Challenges and Opportunities
  • 8:40 AM – 9:30 AM PST
    The Fraud Factory: Inside a $450 Million Healthcare Fraud Acquittal and How You Can Avoid Being a Target
  • 9:40 AM – 10:30 AM PST
    (Unmasking Subjectivity: The Complex World of AI in Pain Assessment) Round III: The Final Debate, Does AI Improve Equity Amongst Disadvantaged Groups? What Do YOU Think?!?
  • 9:40 AM – 10:30 AM PST
    Tearin ’ Up My Heart: Avoiding Cardiovascular Complications with Pain Pharmacotherapy
  • 9:40 AM – 10:30 AM PST
    Why'd You Have to Go Make Things So Complicated? Managing Patients With Multiple Chronic Pain Conditions
  • 10:30 AM – 11:00 AM PST
    Exhibit Hall Break
  • 10:35 AM – 10:45 AM PST
    (Scientific Abstract Poster Live Presentation) Cebranopadol effects on ventilatory drive, central nervous system, and pain
  • 11:00 AM – 11:50 AM PST
    Hitting a Nerve! Management of Chemotherapy-Induced Neuropathic Pain
  • 11:00 AM – 11:50 AM PST
    Joining the Fight: Transitional Pain Services for Postsurgical Pain
  • 11:00 AM – 11:50 AM PST
    Q&A on the Future of Psychedelic Medicine
  • 12:00 PM – 1:00 PM PST
    Lunch on Your Own
  • 1:10 PM – 2:00 PM PST
    Leveraging Non-Invasive Transcutaneous Neuromodulation Devices for Treatment of Pain
  • 1:10 PM – 2:00 PM PST
    Living on the Edge: Pain, Substance Use Disorders and Suicide
  • 1:10 PM – 2:00 PM PST
    Walking on Spikes or Clouds? Diabetic Peripheral Neuropathic Pain Treatment Options
  • 2:15 PM – 2:45 PM PST
    Closing Reception/Raffle Drawing